Antifibrinolytic therapy for ruptured intracranial aneurysms

Completed

Phase N/A Results

Summary of Purpose

To determine the value and relative risks of tranexamic acid (TXA) in the management of ruptured intracranial aneurysms.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 July 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Double-blind, placebo-controlled trial of 100 patients at a single center.

Contacts

Not available